• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FineHeart Successfully Tests Wireless TET System

    Apria Healthcare Settles Whistleblower Lawsuit

    OraSure’s OMNIgene·ORAL Device Included in COVID-19 EUA Amendment

    Remote Patient Monitoring Market Set to Surpass $645 Million by 2025

    4C Medical Technologies Completes $10 Million Over-Subscribed Convertible Note Financing
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Medicoil

    FUTEK Advanced Sensor Technology Inc.

    PTI Engineered Plastics Inc.

    Creganna Medical, part of TE Connectivity

    Qosina Corp.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Medicoil

    K-Tube Technologies

    Creganna Medical, part of TE Connectivity

    Spectrum Plastics Group

    Concise Engineering
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Top30

    7. Cardinal Health

    ...

    Related CONTENT
    • The 2019 Top 30 Global Medical Device Companies
    • 1. Medtronic
    • 2. Johnson & Johnson
    • 7. Siemens Healthineers
    • 9. Stryker
    07.30.19
    AT A GLANCE
    Rank: #7 (Last year: #7)
    $15.58 Billion ($136.8B total)
    Prior Fiscal: $13.52 Billion
    Percentage Change: +15.0%
    No. of Employees: 50,200 (total)
    Global Headquarters: Dublin, Ohio

    KEY EXECUTIVES
    Gregory B. Kenny, Independent Board Chairman
    Michael C. Kaufmann, CEO
    Jorge M. Gomez, CFO
    Jon L. Giacomin, CEO, Medical Segment
    Victor Crawford, CEO, Pharmaceutical Segment
    Michele A. M. Holcomb, Exec. VP, Strategy and Corporate Development
    Craig S. Morford, Chief Legal and Compliance Officer
    Patricia B. Morrison, Exec. VP, Customer Support Services
    and Chief Information Officer
    Jessica L. Mayer, Exec. VP, Deputy General Counsel and Corporate Secretary

    “Lots of companies don’t succeed over time. What do they do fundamentally wrong? They usually miss the future.” — Larry Page, Alphabet Inc. CEO

    How to (truly) Succeed in Business Without Really Trying: Ditch the handbook and heed Page’s advice.

    It works. But not without really trying.

    Virginia “Ginni” Rometty can vouch for the results, as Page’s wisdom has helped her orchestrate IBM’s protracted transformation into a cloud-based “solutions” business. During her tenure as CEO, the 61-year-old has invested billions of dollars in advanced technologies like AI and quantum computing, and sold off legacy assets that no longer fit the company’s revamped business model (last December, for example, IBM divested seven software products, including BigFix, Unica, and Connections).

    Rometty, however, wasn’t always a devotee of Page’s business stratagem. When she first assumed leadership of IBM in January 2012, Rometty dutifully adopted her predecessor’s game plan—i.e., doubling the multinational conglomerate’s per-share earnings by 2015 ($20/share).

    Yet more than two years into her tenure (and just 15 months from the deadline), Rometty realized the growth scheme she inherited would seriously hamper IBM’s efforts to reinvent itself (clearly a case of How Not to Succeed in Business, Despite Really Trying). Thus, she switched gears in October 2014, taking full ownership of the company’s future.

    Securing that future hasn’t been easy, though (despite claims to the contrary from Shepherd Mead’s book and the Pulitzer Prize-winning Broadway musical). Amid its transformation, IBM endured 22 consecutive quarters of freefalling revenue and repeated bouts of frailty from a strengthening U.S. dollar. But a strict regimen of divestitures and strategic acquisitions seem to have helped the company recover its financial fortitude: net income last year skyrocketed 51.7 percent to $8.73 billion, and total revenue climbed 1 percent to $79.6 billion.

    “I really believe the company has in its DNA the ability to change. We’ve done it over and over again,” Rometty told the Harvard Business Review two years ago. “...this is a more extensive transformation because of the convergence of multiple trends that are accelerating the pace of change. It doesn’t matter if you’re an insider so long as you don’t try to protect the past. Then you have the freedom to revinvent yourself for the long term.”

    Cardinal Health CEO Michael Kaufmann is realizing the value in Rometty’s advice as he re-evaluates his company’s product portfolio, business mix, and cost structure. Like Rometty’s predecessor, Kaufmann has established a deadline-oriented growth plan—more than $200 million in annual savings by fiscal 2020—but he’s not depending on past practices to achieve it. Nor is he committing to any one specific approach.

    “Let me be clear about the road ahead. I am not wed to the past,” Kaufmann, CEO since January 2018, told analysts last summer. “Everything is on the table when it comes to driving long-term growth, delivering shareholder returns, and serving our customers. All of us are committed to being disciplined, with a laser focus on achieving results in the months and years ahead.”

    Such results are already starting to materialize: Cardinal Health’s overall revenue jumped 5 percent in FY18 to $136.8 billion, driven by solid gains in both of its business reporting segments. Strong drug distribution and specialty customer sales boosted Pharmaceutical proceeds 4 percent to $121.24 billion, while the July 2017 deal for Medtronic plc’s Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses (Patient Recovery) helped catapult Medical sales 15 percent to $15.58 billion. The $6.1 billion purchase of 23 hospital product brands added $1.9 billion in revenue to Cardinal Health’s coffers, according to the company’s fiscal 2018 annual report (for the year ended June 30, 2018).


    ANALYST INSIGHTS: Cardinal Health has been busy integrating the former Covidien Supplies business (recently purchased from Medtronic) into its operations. With that behind it, look for Cardinal to look for new M&A activities in areas where it can improve its profitability through higher margins than most of its current businesses.

    —Dave Sheppard, Co-Founder and Managing Director, MedWorld Advisors



    The Patient Recovery acquisition also boosted Medical segment profit by 16 percent (to $662 million), though it was somewhat offset by inventory challenges and higher operating expenses in the Cordis business. Cardinal Health purchased Cordis from Johnson & Johnson in 2015 to expand its global footprint and diversify its product offering, particularly in the cardiovascular space.

    Cordis has served its purpose well over the past several years—and that, oddly enough, is part of the problem. To accommodate its broadened product line and overseas business growth, Cardinal Health built out its infrastructure, but the expansion ultimately cost more than the company anticipated.

    “Building of that infrastructure has been more expensive than we thought,” Kaufmann admitted during a quarterly earnings call in May 2018. “We’re clearly disappointed and absolutely will own up to that.”

    On its own, the costly infrastructure expansion would have had a minimal impact on finances; but the addition of inventory troubles helped drive down Cardinal Health’s stock price last spring to its lowest point in nearly five years.

    The source of those inventory troubles, ironically, is Cardinal Health’s own attempts at visibility (the company has begun using IT systems to gain a better understanding of existing network inventory). That effort has created a “large inventory write-off,” Kaufmann claims, and been exacerbated by the limited shelf life of many Cardinal Health products. The inventory issues also have impacted the company’s manufacturing plants: Without reliable data on product demand, Cordis has struggled to maximize the efficiency of its facilities.

    Despite all the challenges with inventory visibility, however, the company is confident it can benefit from the lessons it learned from Cordis’ shortcomings. “We still have additional levels of inventory visibility that we would like to see. But we...feel a lot better where we are today, as you can imagine, by having the visibility that we got,” Kaufmann said on the Q3 earnings call. “The biggest area of challenge that we have is not so much in our own systems to seeing inventory visibility. It’s in our consigned inventory. That’s where we have to take it to the next level...to get better visibility there to make sure we don’t have any additional write-off concerns in that part.”

    Those concerns should gradually wane with the continued rollout of IT systems. Cardinal Health executives forecast “a path to profitable growth” for Cordis by the end of fiscal 2019.

    That path became considerably smoother in fiscal 2018 with the U.S. Food and Drug Administration (FDA) approval of the Elu-NIR Drug-Eluting Stent System and FDA panel support for the INCRAFT AAA Stent Graft System.

    Developed by Israeli cardiovascular intervention solution provider Medinol Ltd., the EluNIR stent system features a metallic spring tip and the most narrow strut width of any stent on the U.S. market, the company claims. The device is designed to treat patients with narrowed or blocked coronary arteries. Cordis and Medino forged a long-term U.S. distribution deal for the stent system in October 2017, about a month before the product won FDA approval. The first commercial implants in America were performed in early January 2018 at New York-Presbyterian Hospital/Columbia Medical Center in New York, N.Y., and the Piedmont Heart Institute in Atlanta, Ga.

    Five months after the EluNIR made its U.S. debut, the FDA Circulatory System Devices Panel of the Medical Devices Advisory Committee voted in favor of the INCRAFT AAA Stent Graft System, based on data from the pivotal INSPIRATION trial. The INCRAFT system is an ultra-low profile and flexible endovascular aneurysm repair (EVAR) solution intended to treat infrarenal abdominal aortic aneurysms (AAA).

    Although several EVAR devices currently are available in the United States, treatment options are limited for many AAA patients with small femoral or iliac arteries, or those with heavily calcified/tortuous vessels. The INCRAFT system received CE mark approval in 2014 and is commercially available in Canada and various countries in Europe, the Middle East, South America, and Asia.

    “INCRAFT is an attractive new ultra-low profile EVAR option that allows for bilateral in-situ adjustment during the procedure, helping to minimize the need for additional components or extensions,”Dr. Takao Ohki, chairman and professor of Surgery and chief of Vascular Surgery at the Jikei University School of Medicine (Tokyo) and co-principal INSPIRATION study investigator, said when INCRAFT received full FDA approval in late November 2018.

    The FDA Advisory panel’s approval of INCRAFT occurred just 24 hours before Cardinal Health announced the sale of a majority stake in post-acute care benefits manager naviHealth to a private equity firm. Intended to accelerate its growth, the $650 million deal gives New York, N.Y.-based Clayton, Dubilier & Rice 55 percent ownership of the Nashville, Tenn., startup, and Cardinal Health 45 percent interest, with the right to reacquire the business.

    naviHealth’s technology uses evidence-based protocols and clinical expertise to track patient recoveries and manage discharges in an effort to lower readmission rates and improve clinical decision-making. The company claims its platform has led to a more than 20 percent decrease in post-actue medical expenses.

    “This new investment structure provides naviHealth with the resources needed to support and accelerate its growth trajectory,” Kaufmann said in announcing the deal. “naviHealth’s leadership team, clinical expertise, and proprietary clinical decision support technology are key differentiators in a rapidly growing sector of the healthcare industry. CD&R’s understanding of naviHealth’s business, and their relationships with current and potential customers, will help provide additional value to patients, health systems, and health plans while also allowing Cardinal Health to benefit from future success.”

    The naviHealth deal also will allow Cardinal Health to benefit from a more simplified business mix. To that end, the company sold its China business in November 2017 to Shanghai Pharmaceuticals Holding Co. Ltd. for $861 million. The deal, which included Cardinal Health’s drug and medical product distribution divisions, further cemented Shanghai’s footprint in the Chinese market (the company already had top billing in the Middle Kingdom’s drug development and distribution theater before the deal occurred). The divestiture gives Shanghai Cardinal Health’s 17 distribution centers throughout 322 cities; 11,000 healthcare facilities; and 30 direct-to-patient pharmacies in 22 cities. Shanghai also gained an additional 146,000 square meters of storage space and 7,000 square meters of cold storage capacity.

    Cardinal Health entered the Chinese market nine years ago with the $470 million purchase of Zuellig Pharma China, but the move never really paid off for the company as it was overshadowed by several major domestic players. At the time of the sale, the company ranked a distant eighth in the China’s drug distribution market.

    “It was clear that the returns we were seeing and the prospects for market leadership did not justify maintaining our current position or committing the additional level of investment required for future growth,” Kaufmann wrote in the annual report. 
    Related Searches
    • devices
    • patient
    • fda approval
    • ibm
    Suggested For You
    The 2019 Top 30 Global Medical Device Companies The 2019 Top 30 Global Medical Device Companies
    1. Medtronic 1. Medtronic
    2. Johnson & Johnson 2. Johnson & Johnson
    7. Siemens Healthineers 7. Siemens Healthineers
    9. Stryker 9. Stryker
    10. Baxter 10. Baxter
    18. 3M Health Care 18. 3M Health Care
    19. Olympus 19. Olympus
    22. Dentsply Sirona 22. Dentsply Sirona
    25. Intuitive Surgical 25. Intuitive Surgical
    27. Hologic 27. Hologic
    28. Varian 28. Varian
    29. Hillrom 29. Hillrom
    Cardinal Health Appoints New Medical Segment CEO Cardinal Health Appoints New Medical Segment CEO
    Former Cardinal Health Exec to Lead Battelle Former Cardinal Health Exec to Lead Battelle's Health Business Unit

    Related Top30

    • The 2020 Top 30 Global Medical Device Companies

      The 2020 Top 30 Global Medical Device Companies

      Leadership changes, divestments, and portfolio-building partnerships—through acquisition or collaboration—were common threads among medtech’s largest players.
      MPO Editors 07.21.20

    • The 2019 Top 30 Global Medical Device Companies

      The 2019 Top 30 Global Medical Device Companies

      ...
      Sean Fenske, Michael Barbella, & Sam Brusco, MPO Editorial Staff 07.30.19

    • 1. Medtronic

      1. Medtronic

      ...
      07.30.19


    • 2. Johnson & Johnson

      2. Johnson & Johnson

      ...
      07.30.19

    • 3. GE Healthcare

      3. GE Healthcare

      ...
      07.30.19

    • 4. Abbott

      4. Abbott

      ...
      07.30.19


    • 5. Philips

      5. Philips

      ...
      07.30.19

    • 6. BD

      6. BD

      ...
      07.30.19

    • 7. Siemens Healthineers

      7. Siemens Healthineers

      ...
      07.30.19


    • 9. Stryker

      9. Stryker

      ...
      07.30.19

    • 10. Baxter

      10. Baxter

      ...
      07.30.19

    • 11. Boston Scientific

      11. Boston Scientific

      ...
      07.30.19


    • 12. Danaher

      12. Danaher

      ...
      07.30.19

    • 13. EssilorLuxottica

      13. EssilorLuxottica

      ...
      07.30.19

    • 14. Zimmer Biomet

      14. Zimmer Biomet

      ...
      07.30.19


    Trending
    • Cytotron Gains Breakthrough Status To Treat Breast, Liver, And Pancreatic Cancers
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    • Top 10 Trends In The Medical Device And Equipment Industry
    Breaking News
    • FineHeart Successfully Tests Wireless TET System
    • Apria Healthcare Settles Whistleblower Lawsuit
    • OraSure’s OMNIgene·ORAL Device Included in COVID-19 EUA Amendment
    • Remote Patient Monitoring Market Set to Surpass $645 Million by 2025
    • 4C Medical Technologies Completes $10 Million Over-Subscribed Convertible Note Financing
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    BGG Obtains U.S. Patent on AstaZine Natural Astaxanthin for Heart Function During Exercise
    Qualitas Health/iwi Raises $10 Million in Investment Round
    Aker BioMarine Expands Krill Portfolio with Novel Protein Hydrolysate
    Coatings World

    Latest Breaking News From Coatings World

    Huntsman Finalizes Acquisition of Gabriel Performance Products
    PPG Completes COLORFUL COMMUNITIES Project at School in A. Bangsaothong Samutprakarn, Thailand
    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FineHeart Successfully Tests Wireless TET System
    Apria Healthcare Settles Whistleblower Lawsuit
    OraSure’s OMNIgene·ORAL Device Included in COVID-19 EUA Amendment
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Valeo Pharma Appoints President, COO
    Metrion, LifeArc Extend Neuroscience Alliance
    Grifols Begins COVID-19 Plasma Treatment Trial
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    JLo Beauty Launches at Sephora & Amazon
    Unilever and Alibaba Group Join Forces
    Redken Unveils Acidic Bonding Concentrate Range
    Happi

    Latest Breaking News From Happi

    A Surge in Interest for Supplements & Vitamins
    Manscaped Expands Further in Europe
    Color Street Gives Back
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Super Strong Inks Survive Tough Environments
    Ontex Honored for Mask Production
    TFP Acquires PV3 Technologies
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    OrthoPediatrics Expands Agent Network in Three European Countries
    Studies Show FlareHawk Expandable Cage Delivers Favorable Fusion, Patient Outcomes
    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login